Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Laura M Stephens"'
Autor:
Amira Zaher, Laura M. Stephens, Ann M. Miller, Stacey M. Hartwig, Jeffrey M. Stolwijk, Michael S. Petronek, Zeb R. Zacharias, Thaddeus J. Wadas, Varun Monga, Joseph J. Cullen, Muhammad Furqan, Jon C. D. Houtman, Steven M. Varga, Douglas R. Spitz, Bryan G. Allen
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Pharmacological ascorbate (i.e., intravenous infusions of vitamin C reaching ~ 20 mM in plasma) is under active investigation as an adjuvant to standard of care anti-cancer treatments due to its dual redox roles as an antioxidant in normal tissues an
Externí odkaz:
https://doaj.org/article/ae800cab6bcd4188b2c0616a5d74bf80
Autor:
Muhammad Furqan, Taher Abu-Hejleh, Laura M. Stephens, Stacey M. Hartwig, Sarah L. Mott, Casey F. Pulliam, Michael Petronek, John B. Henrich, Melissa A. Fath, Jon C. Houtman, Steven M. Varga, Kellie L. Bodeker, Aaron D. Bossler, Andrew M. Bellizzi, Jun Zhang, Varun Monga, Hariharasudan Mani, Marina Ivanovic, Brian J. Smith, Margaret M. Byrne, William Zeitler, Brett A. Wagner, Garry R. Buettner, Joseph J. Cullen, John M. Buatti, Douglas R. Spitz, Bryan G. Allen
Publikováno v:
Redox Biology, Vol 53, Iss , Pp 102318- (2022)
Purpose: Platinum-based chemotherapy with or without immunotherapy is the mainstay of treatment for advanced stage non-small cell lung cancer (NSCLC) lacking a molecular driver alteration. Pre-clinical studies have reported that pharmacological ascor
Externí odkaz:
https://doaj.org/article/3029ad560b984a928c853c72d0650fca
Autor:
Jorge A. Soto, Laura M. Stephens, Kody A. Waldstein, Gisela Canedo-Marroquín, Steven M. Varga, Alexis M. Kalergis
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Externí odkaz:
https://doaj.org/article/ef14addc9e324fc9ad2b045498e073b9
Autor:
Laura M. Stephens, Steven M. Varga
Publikováno v:
Vaccines, Vol 9, Iss 6, p 624 (2021)
Respiratory syncytial virus (RSV) is most commonly associated with acute lower respiratory tract infections in infants and children. However, RSV also causes a high disease burden in the elderly that is often under recognized. Adults >65 years of age
Externí odkaz:
https://doaj.org/article/54400ad9177346ee8b451e77f4c6b28a
Autor:
Laura M. Stephens, Steven M. Varga
Publikováno v:
Vaccines, Vol 8, Iss 2, p 177 (2020)
Respiratory syncytial virus (RSV) is the leading cause of lower respiratory infections in infants and young children, accounting for an estimated 3 million hospitalizations annually worldwide. Despite the major health burden, there is currently no li
Externí odkaz:
https://doaj.org/article/6effc5bc56a64f0e884e1b8f3e89718f
Publikováno v:
J Virol
Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infections in children. In humans, natural infection with RSV affords only partial long-term protection from reinfection, and there is no licensed RSV vaccine currently
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b5a23a44b274a1776971b200185384ee
https://doi.org/10.1128/jvi.01502-22
https://doi.org/10.1128/jvi.01502-22
Autor:
Kevin L. Legge, Kathleen A. Ross, Kody A Waldstein, Steven M. Varga, Laura M Stephens, Balaji Narasimhan, Jason S. McLellan
Publikováno v:
J Immunol
Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infection in both young children and in older adults. Despite the morbidity, mortality, and high economic burden caused by RSV worldwide, no licensed vaccine is currently
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f7872e9c1e111d28c57e6f21e3128f3
https://doi.org/10.4049/jimmunol.2100018
https://doi.org/10.4049/jimmunol.2100018
Autor:
Steven M. Varga, Laura M Stephens
Publikováno v:
Future Virol
Respiratory syncytial virus (RSV) is a leading cause of respiratory disease in infants, the elderly and immunocompromised individuals. Despite the global burden, there is no licensed vaccine for RSV. Recent advances in the use of nanoparticle technol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49400ef662d12edf257f648749b3d3f9
https://europepmc.org/articles/PMC7737143/
https://europepmc.org/articles/PMC7737143/
Autor:
Steven M. Varga, Laura M Stephens
Publikováno v:
Vaccines
Vaccines, Vol 8, Iss 177, p 177 (2020)
Vaccines, Vol 8, Iss 177, p 177 (2020)
Respiratory syncytial virus (RSV) is the leading cause of lower respiratory infections in infants and young children, accounting for an estimated 3 million hospitalizations annually worldwide. Despite the major health burden, there is currently no li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::282831a8d95c7032766c53fb69659cd9
https://pubmed.ncbi.nlm.nih.gov/32290326
https://pubmed.ncbi.nlm.nih.gov/32290326
Publikováno v:
J Immunol
Investigating the complex cellular interplay controlling immunopathogenic and immunoregulatory responses is critical for understanding multiple sclerosis (MS) and for developing successful immunotherapies. Our group has demonstrated that CNS myelin-s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::927a0c8522c9573765e156b220f5890d
https://pubmed.ncbi.nlm.nih.gov/32532836
https://pubmed.ncbi.nlm.nih.gov/32532836